Cargando…

JAC4 Alleviates Rotenone-Induced Parkinson’s Disease through the Inactivation of the NLRP3 Signal Pathway

Parkinson’s disease (PD) is the fastest-growing neurodegeneration disease, characterized typically by a progressive loss of dopaminergic neurons in the substantia nigra, and there are no effective therapeutic agents to cure PD. Rotenone (Rot) is a common and widely used pesticide which can directly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Lu, Che, Zhen, Ding, Kun, Zhang, Chao, Liu, Xia, Wang, Luman, Li, Aiping, Zhou, Jianwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215424/ https://www.ncbi.nlm.nih.gov/pubmed/37238000 http://dx.doi.org/10.3390/antiox12051134

Ejemplares similares

JAC4 Protects from X-ray Radiation-Induced Intestinal Injury by JWA-Mediated Anti-Oxidation/Inflammation Signaling
por: Zhou, Yan, et al.
Publicado: (2022)

JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis
por: Ding, Kun, et al.
Publicado: (2023)

Curcumin protects against rotenone-induced Parkinson's disease in mice by inhibiting microglial NLRP3 inflammasome activation and alleviating mitochondrial dysfunction
por: Xu, Long, et al.
Publicado: (2023)

Welcome to JACS Au!
por: Jones, Christopher W.
Publicado: (2021)

JAC1 suppresses proliferation of breast cancer through the JWA/p38/SMURF1/HER2 signaling
por: Ren, Yanlin, et al.
Publicado: (2021)

JACS Au at Pacifichem 2021
por: Jones, Christopher W., et al.
Publicado: (2021)

Growth & Evolution of JACS Au
por: Jones, Christopher W.
Publicado: (2023)

JAC1 targets YY1 mediated JWA/p38 MAPK signaling to inhibit proliferation and induce apoptosis in TNBC
por: Zhai, Zurong, et al.
Publicado: (2022)

Treadmill exercise alleviates depressive symptoms in rotenone-induced Parkinson disease rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

Rotenone, Paraquat, and Parkinson’s Disease
por: Tanner, Caroline M., et al.
Publicado: (2011)

FAQs about Submission to JACS Au
por: Jones, Christopher W.
Publicado: (2021)

JACS Au Enters Year 2
por: Jones, Christopher W., et al.
Publicado: (2022)

Introducing JACS Au ECAB Selects
por: Jones, Christopher W.
Publicado: (2022)

Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

International Open Access Week and JACS Au
Publicado: (2021)

The First JACS Au Outstanding Paper Awards
por: Jones, Christopher W.
Publicado: (2023)

Sericin alleviates motor dysfunction by modulating inflammation and TrkB/BDNF signaling pathway in the rotenone-induced Parkinson’s disease model
por: Salari, Zahra, et al.
Publicado: (2023)

Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery
por: Ding, Kun, et al.
Publicado: (2022)

Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction
por: Aleksandrova, Yulia, et al.
Publicado: (2023)

Complete Genome Sequence of Mycobacteriophage IgnatiusPatJac
por: Jacobs, Olivia, et al.
Publicado: (2022)

JACS Au and International Open Access Week 2022
por: Lawal, Wasiu
Publicado: (2022)

JACS Au Earns First Partial Impact Factor
por: Jones, Christopher W.
Publicado: (2023)

The role of autophagy in Parkinson's disease: rotenone-based modeling
por: Xiong, Nian, et al.
Publicado: (2013)

Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats
por: Zaitone, Sawsan A., et al.
Publicado: (2012)

Introducing the JACS Au Editors: Wasiu Lawal and Christopher Jones
Publicado: (2021)

JACS Au Introduces 2021 Early Career Advisory Board
Publicado: (2021)

Introducing the 2022 JACS Au Early Career Advisory Board
por: Jones, Christopher W.
Publicado: (2022)

Introducing the 2023 JACS Au Early Career Advisory Board
Publicado: (2023)

Barbigerone Potentially Alleviates Rotenone-Activated Parkinson’s Disease in a Rodent Model by Reducing Oxidative Stress and Neuroinflammatory Cytokines
por: Alharthy, Khalid M., et al.
Publicado: (2023)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Introducing the JACS Au Associate Editors: Carole Duboc and Hyunjoo Lee
por: Jones, Christopher W.
Publicado: (2021)

Introducing the JACS Au Associate Editors: Sabine Flitsch and Nuno Maulide
por: Jones, Christopher W.
Publicado: (2021)

Introducing the JACS Au Associate Editors: Rodney Priestley and Xin Xu
por: Jones, Christopher W.
Publicado: (2021)

Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models
por: Zhang, Yu, et al.
Publicado: (2019)

Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism
por: Chiu, Ching-Chi, et al.
Publicado: (2014)

The Pael-R gene does not mediate the changes in rotenone-induced Parkinson's disease model cells
por: Zou, Ting, et al.
Publicado: (2014)

Europinidin Inhibits Rotenone-Activated Parkinson’s Disease in Rodents by Decreasing Lipid Peroxidation and Inflammatory Cytokines Pathways
por: Altharawi, Ali, et al.
Publicado: (2022)

Novel Role of JAC1 in Influencing Photosynthesis, Stomatal Conductance, and Photooxidative Stress Signalling Pathway in Arabidopsis thaliana
por: Czarnocka, Weronika, et al.
Publicado: (2020)

Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2011)

Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_6rp57rkh3fbn8qthsl8r0efqi2